335
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes

, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 489-497 | Published online: 24 Feb 2020

References

  • Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887. doi:10.1038/nature05488
  • Sims EAH. Characterization of the syndromes of obesity. In: Brodoff BN, Bleicher SJ, editors. Diabetes Mellitus and Obesity. Baltimore, MD: Williams & Wilkins; 1982:219–226.
  • Andres R. Effect of obesity on total mortality. Int J Obes. 1980;4:381–386.
  • Samocha-Bonet D, Dixit VD, Kahn CR, et al. Metabolically healthy and unhealthy obese – the 2013 stock conference report. Obes Rev. 2014;15:697–708. doi:10.1111/obr.2014.15.issue-9
  • Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–162. doi:10.1016/S2213-8587(13)70062-7
  • Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35:971–981. doi:10.1038/ijo.2010.216
  • Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR. Insulin-sensitive obesity in humans – a ‘favorable fat’ phenotype? Trends Endocrinol Metab. 2012;23:116–124. doi:10.1016/j.tem.2011.12.005
  • Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–1616. doi:10.1001/archinte.168.15.1609
  • Fabbrini E, Yoshino J, Yoshino M, et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest. 2015;125:787–795. doi:10.1172/JCI78425
  • Società Italiana di Chirurgia dell’Obesità e delle Malattie Metaboliche Chapter 3. 2016;29–34.
  • Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320–3325. doi:10.2337/diacare.26.12.3320
  • Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936–942. doi:10.1093/ajcn/36.5.936
  • Perseghin G, Lattuada G, De Cobelli F, et al. Habitual physical activity is associated with the intra-hepatic fat content in humans. Diabetes Care. 2007;30:683–688. doi:10.2337/dc06-2032
  • van Strien T, Frijters JER, Bergers GPA, Defares PB. The dutch eating behavior questionnaire (DEBQ) assessment of restrained, emotional and external eating behavior. Int J Eat Disord. 1986;5:295–315. doi:10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T
  • Perseghin G, Lattuada G, De Cobelli F, et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia. 2005;48:2615–2621. doi:10.1007/s00125-005-0014-5
  • Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond). 1949;109:1–9. doi:10.1113/jphysiol.1949.sp004363
  • Al-Domi A, Al-Shorman A. Validation of resting metabolic rate equations in obese and non-obese young healthy adults. Clin Nutr ESPEN. 2018;26:91–96. doi:10.1016/j.clnesp.2018.04.008
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1995;28:412–419. doi:10.1007/BF00280883
  • D’ Agostino RB. An omnibus test of normality for moderate and large size samples. Biometrika. 1971;58:341–348. doi:10.1093/biomet/58.2.341
  • Pham DD, Lee JH, Hong KH, Jung YJ, Kim SJ, Leem CH. Seasonal effects on resting energy expenditure are dependent on age and percent body fat. Clin Nutr. 2019;28:S0261-5614(19)30232–8.
  • Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome–an allostatic perspective. Biochim Biophys Acta. 2010;1801:338–349. doi:10.1016/j.bbalip.2009.12.006
  • Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia. 2008;51:1752–1754. doi:10.1007/s00125-008-1038-4
  • Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features and prognosis of metabolically-healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011;34:210–215. doi:10.2337/dc10-0665
  • Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714–724. doi:10.1016/S2213-8587(18)30137-2
  • Kim HK, Nilius B, Kim N, Ko KS, Rhee BD, Han J. Cardiac response to oxidative stress induced by mitochondrial dysfunction. Rev Physiol Biochem Pharmacol. 2016;170:101–127.
  • Sasongko MB, Widyaputri F, Sulistyoningrum DC, et al. Estimated resting metabolic rate and body composition measures are strongly associated with diabetic retinopathy in Indonesian adults with type 2 diabetes. Diabetes Care. 2018;41:2377–2384. doi:10.2337/dc18-1074
  • Ludwig DS, Ebbeling CB. The carbohydrate-insulin model of obesity beyond “calories in, calories out”. JAMA Intern Med. 2018;178:1098–1103. doi:10.1001/jamainternmed.2018.2933